Correlation Between TERADATA and Diamyd Medical

Can any of the company-specific risk be diversified away by investing in both TERADATA and Diamyd Medical at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining TERADATA and Diamyd Medical into the same portfolio, which is an essential part of the fundamental portfolio management process.

By analyzing existing cross correlation between TERADATA and Diamyd Medical AB, you can compare the effects of market volatilities on TERADATA and Diamyd Medical and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in TERADATA with a short position of Diamyd Medical. Check out your portfolio center. Please also check ongoing floating volatility patterns of TERADATA and Diamyd Medical.

Diversification Opportunities for TERADATA and Diamyd Medical

0.4

Correlation Coefficient

TERADATA  Diamyd Medical

Very weak diversification

The 3 months correlation between TERADATA and Diamyd is 0.4. Overlapping area represents the amount of risk that can be diversified away by holding TERADATA and Diamyd Medical AB in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Diamyd Medical AB and TERADATA is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on TERADATA are associated (or correlated) with Diamyd Medical. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Diamyd Medical AB has no effect on the direction of TERADATA i.e., TERADATA and Diamyd Medical go up and down completely randomly.

Pair Corralation between TERADATA and Diamyd Medical

Assuming the 90 days trading horizon TERADATA is expected to generate 23.92 times less return on investment than Diamyd Medical. But when comparing it to its historical volatility, TERADATA is 5.6 times less risky than Diamyd Medical. It trades about 0.05 of its potential returns per unit of risk. Diamyd Medical AB is currently generating about 0.22 of returns per unit of risk over similar time horizon. If you would invest  125.00  in Diamyd Medical AB on October 5, 2024 and sell it today you would earn a total of  21.00  from holding Diamyd Medical AB or generate 16.8% return on investment over 90 days.

Time Period	3 Months [change]
Direction	Moves Together
Strength	Weak
Accuracy	100.0%
Values	Daily Returns

TERADATA  vs.  Diamyd Medical AB

TERADATA

Risk-Adjusted Performance

0 of 100

Good

Over the last 90 days TERADATA has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of comparatively uncertain basic indicators, TERADATA may actually be approaching a critical reversion point that can send shares even higher in February 2025.

Diamyd Medical AB

Risk-Adjusted Performance

0 of 100

OK

Over the last 90 days Diamyd Medical AB has generated negative risk-adjusted returns adding no value to investors with long positions. Despite nearly fragile basic indicators, Diamyd Medical reported solid returns over the last few months and may actually be approaching a breakup point.

Pair Trading with TERADATA and Diamyd Medical

The main advantage of trading using opposite TERADATA and Diamyd Medical positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if TERADATA position performs unexpectedly, Diamyd Medical can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Diamyd Medical will offset losses from the drop in Diamyd Medical's long position.

The idea behind TERADATA and Diamyd Medical AB pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.

Check out your portfolio center.

Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Competition Analyzer module to analyze and compare many basic indicators for a group of related or unrelated entities.